Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Patent
1991-11-14
1996-06-11
Bawa, Raj
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
424486, 514944, A61K 910
Patent
active
055253563
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE INVENTION
This invention relates to polymeric hydrogels for use on medical devices such as iontophoresis, sensing electrodes stimulation electrodes, wound dressings, passive drug delivery devices and the like to adhere the device to the patient's skin. The invention also relates to hydrogels for implantable drug delivery reservoirs, cushions for implantable devices such as heart pacemakers, defibrilators, leads, catheters, and the like.
BACKGROUND OF THE INVENTION
Polymeric, conductive hydrogels have been used in medical devices to adhere the device to a patient's skin, such as biomedical electrodes to provide a secure, conductive connection between the medical device and the patient's skin for stimulation or sensing purposes. However, in certain applications such as iontophoresis devices, known hydrogel compositions possess significant disadvantages.
Iontophoresis is a method for introducing active pharmaceutical agents into a patient. The method utilizes electrical current to transport the active agents, which are usually in charged form, but may also be uncharged, through the skin, mucosa or other body surface of the patient. The iontophoresis process has been found to be useful in the administration of lidocaine hydrochloride, hydrocortisone derivatives, penicillin, dexamethasone sodium phosphate and many other pharmaceutical agents. Iontophoretic methods have also been employed to deliver uncharged therapeutic agents by the mechanism of induced solvent flow.
Iontophoretic devices employ two electrodes. The first electrode, called the active electrode, is the element from which the active agent is transported into the body. The second electrode, called the counter or ground electrode, serves to complete the electrical circuit through the body. In typical applications, the active electrode holds, contains or otherwise has available to it a source of the active agent. Thus, the active electrode is usually complex compared to the counter electrode.
U.S. Pat. No. 4,820,263 discloses a combination of an adhesive material and active agent for use as the active electrode. The adhesive material is a nontoxic, polymeric material that is or can be made tacky and can dissolve or disperse pharmaceutical agents.
Additional disclosure regarding iontophoresis devices can be found in our copending application Ser. No. 07/502,841 "Device and Method For Iontophoretic Drug Delivery" which is incorporated herein by reference.
Hydrogels are also known to be used for other medical purposes such as to secure other medical devices such as electrodes, bandages and the like to the human body and when so applied to provide necessary conductivity, wound protection, medicament delivery and other desirable properties for the operation of the device.
U.S. Pat. No. 4,904,247 discloses a pressure-sensitive hydrophilic laminate composite for wound dressing in which one layer of the laminate is a tacky hydrophilic polymer blend and a second layer is a non-tacky hydrophilic polymer blend. The tacky hydrophilic polymer layer is adapted for attachment to skin.
U.S. Pat. No. 4,391,278 discloses a skin electrode for sensing and stimulation utilizing a conductive adhesive mixture of a polymerized form of 2-acrylamido-2-methylpropane sulfonic acid or one of its salts with water and/or an alcohol for attachment of the electrode to the patient's skin.
U.S. Pat. No. 4,570,629 discloses a hydrophilic biopolymer comprising a water soluble anionic protein electrolyte component derived from keratin and a water soluble cationic biopolymer poly electrolyte component selected from glucosaminoglycan and collagen for use in treating burned human skin.
However, known hydrogels have significant disadvantages in some applications due to the ionic structure of the adhesive composition. For example, iontophoresis electrodes constructed using known ionic hydrogel adhesives readily adhere to the skin but the ionic polymer and charged pharmaceutical agent tend to combine chemically into salts, thereby causing a diminished transfer of the agent th
REFERENCES:
patent: 3428043 (1969-02-01), Shepherd et al.
patent: 3783869 (1974-01-01), Schnipper
patent: 4078568 (1978-03-01), Etes et al.
patent: 4153055 (1979-05-01), Etes
patent: 4226232 (1980-10-01), Spence
patent: 4384898 (1983-05-01), Okada et al.
patent: 4391278 (1983-07-01), Cahalan et al.
patent: 4391799 (1983-07-01), Mason, Jr. et al.
patent: 4393048 (1983-07-01), Mason, Jr. et al.
patent: 4486193 (1984-12-01), Shaw et al.
patent: 4552138 (1985-11-01), Hofeditz et al.
patent: 4556056 (1985-12-01), Fischer
patent: 4570629 (1986-02-01), Widra
patent: 4581821 (1986-04-01), Cahalan et al.
patent: 4593053 (1986-06-01), Jevne et al.
patent: 4650484 (1987-03-01), Shaw et al.
patent: 4659572 (1987-04-01), Murray
patent: 4699146 (1987-10-01), Sieverding
patent: 4704119 (1987-11-01), Shaw et al.
patent: 4706680 (1987-11-01), Keusch et al.
patent: 4725272 (1988-02-01), Gale
patent: 4750482 (1988-06-01), Sieverding
patent: 4767619 (1988-08-01), Murray
patent: 4768523 (1988-09-01), Cahalan et al.
patent: 4777954 (1988-10-01), Keusch et al.
patent: 4781921 (1988-11-01), Smith et al.
patent: 4820263 (1989-04-01), Spevak et al.
patent: 4830776 (1989-05-01), Thompson
patent: 4842597 (1989-06-01), Brook et al.
patent: 4846826 (1989-07-01), Shaw et al.
patent: 4867821 (1989-09-01), Morgan et al.
patent: 4889530 (1989-12-01), Smith et al.
patent: 4904247 (1990-02-01), Therriault et al.
patent: 4909244 (1990-03-01), Quarfoot et al.
patent: 4920158 (1990-04-01), Murray et al.
patent: 4930500 (1990-06-01), Morgan
Biological Tolerance of Poly(N-Substituted Acrylamides); J. Kopecek, L. Sprincl, H. Bazilova and J. Vacik; Institute of Macromolecular Chemistry, Czechoslovak Academy of Sciences, Prague; J. Biomed Mater, Res.; vol. 7, pp. 111-121 (1973).
Polymerization of Vinylpyridinium Salts, IX., Preparation of Monomeric Salt Pairs; Polymer Letters Edition, vol. 15, pp. 487-491 (1977).
Holmblad Carolann
Howland Warren W.
Jevne Allan H.
Phipps Joseph B.
Bawa Raj
Latham Daniel W.
Medtronic Inc.
Patton Harold R.
LandOfFree
Amphoteric N-substituted acrylamide hydrogel and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amphoteric N-substituted acrylamide hydrogel and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amphoteric N-substituted acrylamide hydrogel and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-350376